| [1] |
ZHENG Liqiang, LI Chengxin. Update of the treatment of severe alopecia areata [J]. China Journal of Leprosy and Skin Diseases, 2018, 34(3): 176
-180
. |
| [2] |
JIANG Wei, LI Shuli, LI Chunying.. Update of treatment of vitiligo with statins[J]. China Journal of Leprosy and Skin Diseases, 2018, 34(3): 185
-187
. |
| [3] |
WU Lili, CHEN Yun . Upate of bioavailability and bioequivalence of topical dermatological drugs[J]. China Journal of Leprosy and Skin Diseases, 2018, 34(9): 573
-576
. |
| [4] |
YAO Likun. Clinical application of metformin in dermatology[J]. China Journal of Leprosy and Skin Diseases, 2019, 35(7): 437
-440
. |
| [5] |
WANG Zihong, BAI Bingxue. Research progress of thebiologicals for treating atopic dermatitis[J]. China Journal of Leprosy and Skin Diseases, 2019, 35(7): 445
-448
. |
| [6] |
XIONG Li, HE Jun, YANG Jun, LI Daijiao. Analysis of disability among the newly diagnosed leprosy patients in Yunnan Province from 1990 to 2018[J]. China Journal of Leprosy and Skin Diseases, 2019, 35(10): 608
-610
. |
| [7] |
FU Tao, LI Dongqin.
Clinical analysis of 98 patients with dermatomyositis
[J]. China Journal of Leprosy and Skin Diseases, 2019, 35(11): 679
-682
. |
| [8] |
GAO Xiaoman, LI Ming, LIU Wan, YANG Min, CHANG Jianmin. Analysis of patch test on 82 cases of vulvar lichen simplex chronicus[J]. China Journal of Leprosy and Skin Diseases, 2019, 35(12): 707
-709
. |
| [9] |
LI Ge, WANG Yaofei, WANG Guan, LIN Zhaoxing . Epidemiological characteristics of leprosy in Shaanxi Province from 1998 to 2018[J]. China Journal of Leprosy and Skin Diseases, 2019, 35(12): 715
-718
. |
| [10] |
MA Jing, CAI Xinying, XIAO Fengli. Update on vitiligo susceptibility genes[J]. China Journal of Leprosy and Skin Diseases, 2019, 35(12): 762
-764
. |
|
